Immediate Impact
19 from Science/Nature 58 standout
Citing Papers
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
2023 Standout
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
2023 Standout
Works of Alexandre Marcil being referenced
Amyloid-β1-15/16 as a Marker for γ-Secretase Inhibition in Alzheimer's Disease
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alexandre Marcil | 231 | 31 | 74 | 84 | 7 | 370 | |
| Renee Sears | 269 | 38 | 58 | 81 | 7 | 368 | |
| Fangdong Zou | 247 | 32 | 86 | 105 | 13 | 407 | |
| Erica Bello | 249 | 24 | 111 | 115 | 7 | 363 | |
| Smitha Sreedharan | 166 | 71 | 52 | 66 | 10 | 350 | |
| Rita Holdhus | 149 | 20 | 63 | 64 | 9 | 301 | |
| Christiane Kummer | 139 | 22 | 72 | 66 | 10 | 331 | |
| Julian Schumacher | 149 | 14 | 56 | 50 | 7 | 306 | |
| Coralie Rummel | 190 | 34 | 27 | 40 | 8 | 388 | |
| Alisa A. Shaimardanova | 238 | 25 | 111 | 156 | 13 | 380 | |
| Tracy Kojis | 237 | 88 | 35 | 74 | 9 | 377 |
All Works
Loading papers...